October 23, 2014 1:34 PM ET

Biotechnology

Company Overview of OPKO Biologics

Executive Profile

Eyal Fima M.B.A., Ph.D.

Chief Executive Officer, NatSpears
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 1 different industries.

49--

Background

Dr. Eyal Fima, M.B.A., Ph.D. has been the Chief Operating Officer of ModigeneTech at OPKO Biologics since January 2010. Dr. Fima served as Vice President, Product Development of ModigeneTech., at Modigene, Inc. from November 2005. to January 2010. Dr. Fima Co-Founded NatSpears Ltd. and served as its Chief Executive Officer from 2001 to 2002. Dr. Fima was a research fellow at the Immunology Department of Ben-Gurion University in Israel from 2002 to 2005, where he researched ...

Corporate Headquarters

7 Golda Meir Street
Nes-Ziona, -- 74140

Israel

Phone: 866 644 7811
Fax: 972 8 930 0091

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Ben-Gurion University
MBA
Guilford Glazer School of Business and Management, Ben-Gurion University of the Negev

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPKO Biologics, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.